Celanese Corporation: Celanese to Sell Additional Shares of Nutrinova Joint Venture to Mitsui & Co., Ltd.
Celanese (NYSE: CE) will sell an additional 19% stake in Nutrinova to Mitsui for $152M, retaining an 11% interest. The deal supports its deleveraging plans and is expected to close in Q4. Celanese will operate a diketene facility for Nutrinova, receiving the purchase price and operating costs.
How this was made
The 30-second read
Why it matters
The transaction provides immediate liquidity, lowers net debt, and may improve credit metrics, supporting a positive equity reaction.
Market read
A material cash‑generating divestiture for a mid‑cap industrial firm, likely to influence its stock and debt metrics.
What to watch
Future earnings from the retained 11% stake and the operational responsibilities for the diketene facility could affect cash flow.
Background
Celanese is pursuing a $1 billion divestiture plan through 2027 to deleverage its balance sheet.
Ticker impact
Celanese announced the sale of an additional 19% stake in its Nutrinova JV to Mitsui for approximately $152 million, providing cash to reduce debt.
Potential short‑term upside as investors price in debt reduction and a clearer capital structure.
A $152 M cash receipt is material for a mid‑cap chemical company and is the first public disclosure of the transaction.
Market effects
The deal highlights ongoing consolidation in specialty chemicals and may prompt peers to consider similar asset sales.
European chemical markets could see modest re‑pricing as a major player reduces exposure in a food‑ingredients JV.
Limited to investors focused on industrial and specialty chemicals; broader market impact is minimal.
Counterpoint
The sale reduces Celanese's upside potential in the high‑growth Nutrinova business, possibly weighing on long‑term earnings.
Key entities
- CompanyCelanese Corporation
US‑listed specialty chemicals producer (NYSE: CE).
- CompanyMitsui & Co., Ltd.
Japanese conglomerate acquiring additional stake in Nutrinova.
